Work

Efficacy and safety of intramuscular (IM) recombinant Erwinia asparaginase in acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL): The Children’s Oncology Group (COG) AALL1931 study.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.7001

Authors: Luke Devon Maese, Mignon L. Loh, L. Mi Rim Choi, Tong Lin, Etsuko Aoki, Michelle Zanette, Shirali Agarwal, Jeffrey Alan Silverman, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau

Institutions: Primary Children's Hospital, Huntsman Cancer Institute, Seattle Children's Hospital, Jazz Pharmaceuticals (United States), Boston Children's Hospital, Dana-Farber Cancer Institute, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, NYU Langone Health, Baylor College of Medicine

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Jazz Pharmaceuticals

OpenAlex ID: W4286295765

Cites:

Cited by: 1

Related to: 10